Life Tech Freestyle 293 Expression Medium and EXPI293 Expression Medium

Closed Solicitation Posted

Solicitation number
RFQ-NIAID-25-2270196
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6810 Chemicals
Place of performance
Bethesda, Maryland 20892, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center is seeking to procure specialized cell culture media products essential for vaccine development research, specifically Life Technologies' Freestyle 293 Expression Medium and EXPI293 Expression Medium. These expression mediums are critical for protein and antibody production in vaccine development research targeting HIV-1, SARS-CoV-2, and other viruses, supporting high-density protein growth protocols unique to the center's research requirements. The solicitation (RFQ-NIAID-25-2270196) is being conducted under Simplified Acquisition Procedures as a combined synopsis/solicitation for commercial items, with full and open competition subject to a brand name restriction limiting procurement to Life Technologies products. The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) with a small business size standard of 1,250 employees. Quotes are due by September 16, 2025, with the government intending to award a firm fixed-price purchase order incorporating standard federal contract terms and conditions.

This procurement does not utilize any small business set-aside designations and is being competed under full and open competition, though the brand name restriction effectively limits the award to Life Technologies Corporation as the sole source provider. The total estimated contract value is $63,396.00, covering the procurement of 12 units of Freestyle 293 Expression Medium (catalog #12338018/11338026) and 240 units of EXPI293 Expression Medium (catalog #A1435101). Delivery is required within 30 days after receipt of order to the NIAID facility located at 40 Convent Drive in Bethesda, Maryland, with FOB terms set to destination. The performance period is structured from August 1, 2023, to July 31, 2024, though delivery dates may vary based on multiple delivery schedules. The procurement specifically targets commercially available products that meet the unique specifications required for the Vaccine Research Center's ongoing vaccine development protocols.

Notice text

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2270196 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-05, Effective 08/07/2025. 

The North American Industry Classification System (NAICS) code for this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing, with a small business size standard of 1250 employees.

This requirement is being competed full and open competition, with a Brand Name restriction (see attachment) and without a small business set-aside.

The Vaccine Research Center (VRC) of NIAID is seeking to procure Life Tech Freestyle 293 Expression Medium and EXPI293 Expression Medium. See attachments.

Manufacturer:

Life Technologies

Product needed:

Line

Description

Catalog #

QTY

1

Freestyle 293 Expression Med 6x1000mL includes  6QTY Component 12338018

11338026

12

2

EXPI293 EXPRESSION MEDIUM 1000 mL

A1435101

240

Delivery location:

NIAID

40 Convent Dr

Bethesda, MD 20892

Delivery Date:

30 days ARO (Multiple delivery dates_

FOB: Destination

* By submitting a quotation, you are accepting that all government terms and conditions set forth herein shall prevail over the award.

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based the lowest price technically acceptable. By submitting a quotation, you are accepting that all government terms and conditions set forth herein shall prevail over the award. The technical evaluation will be based on the following: technical capability to meet the requirements listed on the attachment, and then price.

The following FAR provisions apply to this acquisition:

FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021)

FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020)

FAR 52.212-1 Instructions to Offerors Commercial Items (Sep 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (May 2024)

Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (Jan 2017)

The following FAR contract clauses apply to this acquisition:

FAR 52.212-4 Contract Terms and Conditions Commercial Items (Nov 2023)

FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Nov 2023)

*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.203-19 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Jan 2017)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021)

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Mar 2023)

FAR 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015)

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Offers may be e-mailed to Ms. Skye Duffner, (E-Mail/ skye.duffner@nih.gov 240-236-9582). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency. 

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Ms. Skye Duffner at skye.duffner@nih.gov.

Attachments

Files attached to this notice, newest first
File Type Posted
2_JA 2270196.docx DOCX document
52.212-5 Jan 2025 Supplies.docx DOCX document

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity